Clinical Trial Update: Expanded Access Protocol for Boys With Duchenne Muscular Dystrophy

View source ↗

Summary

This update covers an Expanded Access Protocol for boys with Duchenne Muscular Dystrophy sponsored by Santhera Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Snippet

Sponsor: Santhera Pharmaceuticals | Conditions: Duchenne Muscular Dystrophy | Status: AVAILABLE